Late-stage borreliosis and substance abuse.

Addiction Borreliosis Drug abuse Homicide Lyme disease Persistent lyme disease Phencyclidine Post treatment lyme disease Suicide Tick-borne relapsing fever

Journal

Heliyon
ISSN: 2405-8440
Titre abrégé: Heliyon
Pays: England
ID NLM: 101672560

Informations de publication

Date de publication:
30 May 2024
Historique:
received: 30 11 2023
revised: 09 05 2024
accepted: 10 05 2024
medline: 23 5 2024
pubmed: 23 5 2024
entrez: 23 5 2024
Statut: epublish

Résumé

Infectious diseases can contribute to substance abuse. Here, a fatal case of borreliosis and substance abuse is reported. This patient had a history of multiple tick bites and increasing multisystem symptoms, yet diagnosis and treatment were delayed. He experimented with multiple substances including phencyclidine (PCP), an N-methyl-d-aspartate (NMDA) receptor antagonist that opposes NMDA agonism caused by Brain tissue was obtained from autopsy and stained for microglial activation and quinolinic acid (QA). Immunoflouresence (IFA) and fluorescence Autopsy tissue evaluation demonstrated Late-stage borreliosis is associated with multiple symptoms that may contribute to an increased risk of substance abuse and addictive disorders. More effective diagnosis and treatment of borreliosis, and attention to substance abuse potential may help reduce associated morbidity and mortality in patients with borreliosis, particularly in endemic areas.

Sections du résumé

Background UNASSIGNED
Infectious diseases can contribute to substance abuse. Here, a fatal case of borreliosis and substance abuse is reported. This patient had a history of multiple tick bites and increasing multisystem symptoms, yet diagnosis and treatment were delayed. He experimented with multiple substances including phencyclidine (PCP), an N-methyl-d-aspartate (NMDA) receptor antagonist that opposes NMDA agonism caused by
Methods UNASSIGNED
Brain tissue was obtained from autopsy and stained for microglial activation and quinolinic acid (QA). Immunoflouresence (IFA) and fluorescence
Results UNASSIGNED
Autopsy tissue evaluation demonstrated
Conclusions UNASSIGNED
Late-stage borreliosis is associated with multiple symptoms that may contribute to an increased risk of substance abuse and addictive disorders. More effective diagnosis and treatment of borreliosis, and attention to substance abuse potential may help reduce associated morbidity and mortality in patients with borreliosis, particularly in endemic areas.

Identifiants

pubmed: 38779029
doi: 10.1016/j.heliyon.2024.e31159
pii: S2405-8440(24)07190-1
pmc: PMC11108998
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e31159

Informations de copyright

© 2024 The Authors. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:Monica E. Embers, Liz Horn reports financial support was provided by Bay Area Lyme Foundation. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Robert C Bransfield (RC)

Rutgers-RWJ Medical School, Piscataway, NJ, USA. Hackensack Meridian Health-School of Medicine, Nutley, NJ, USA.

Shiva Kumar Goud Gadila (SK)

Division of Immunology, Tulane National Primate Research Center, Tulane University Health Sciences, Covington, LA, USA.

Laura J Kursawe (LJ)

Charité - Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin, Charitéplatz 1, 10117, Berlin, Germany.

Andrew J Dwork (AJ)

Department of Psychiatry, Columbia University, New York, NY, United States. Division of Molecular Imaging and Neuropathology, New York, USA.
State Psychiatric Institute, New York, NY, USA.
Macedonian Academy of Sciences and Arts, Skopje, Macedonia.
Department of Pathology and Cell Biology, Columbia University, New York, NY, USA.

Gorazd Rosoklija (G)

State Psychiatric Institute, New York, NY, USA.
Department of Pathology and Cell Biology, Columbia University, New York, NY, USA.

Elizabeth J Horn (EJ)

Lyme Disease Biobank, Portland, OR, USA.

Michael J Cook (MJ)

Independent Researcher, Dorset, BH23 5BN, UK.

Monica E Embers (ME)

Division of Immunology, Tulane National Primate Research Center, Tulane University Health Sciences, Covington, LA, USA.

Classifications MeSH